ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Gtx, Inc.

Gtx, Inc. (GTXI)

1.20
0.00
( 0.00% )
更新日時: 09:00:00

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
1.20
買値
1.18
売値
1.20
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
1.20
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

GTXI 最新ニュース

Garrett Motion Common Stock Debuts on Nasdaq Global Select Market Under Ticker Symbol GTX

Garrett Motion Inc. (Nasdaq: GTX) announced today its common stock has commenced trading on the Nasdaq Global Select Market, which has the highest listing standards at the exchange, under the...

Factors of Influence in 2019, Key Indicators and Opportunity within Adobe, CareTrust REIT, Ball, Equinix, Assembly Bioscience...

NEW YORK, April 15, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders...

GTx & Oncternal Therapeutics Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing...

-- Merger will combine Oncternal’s clinical stage oncology pipeline and expertise with GTx’s preclinical Selective Androgen Receptor Degrader (SARD) program for castration-resistant prostate...

Analysis: Positioning to Benefit within Skyworks Solutions, Atmos Energy, Ellie Mae, ScanSource, REV Group, and GTx — Resea...

NEW YORK, Feb. 07, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders...

GTx Reports Third Quarter 2018 Financial Results and Provides Corporate Update

GTx, Inc. (Nasdaq: GTXI) today reported financial results for the third quarter ended September 30, 2018, and provided a corporate update. “During the quarter, we turned our focus to the...

GTx Announces Top-Line Results from Placebo-Controlled ASTRID Trial of Enobosarm in Women with Stress Urinary Incontinence

GTx, Inc. (Nasdaq: GTXI) today announced that the ASTRID Trial, a Phase 2 double-blind, placebo-controlled clinical trial of orally-administered enobosarm (3 mg or 1 mg) in post-menopausal...

GTx, Inc. to Participate in the Baird 2018 Global Healthcare Conference

GTx, Inc. (Nasdaq: GTXI) today announced that Robert J. Wills, PhD, Executive Chairman, and other senior executive management team members will present a company overview at the Baird 2018...

GTx Provides Corporate Update and Reports Second Quarter 2018 Financial Results

-- Completed patient enrollment in the ASTRID Trial, a Phase 2 double-blinded, placebo-controlled clinical trial of enobosarm in Stress Urinary Incontinence -- -- Top-line results from...

GTx Added to the Russell 3000® Index

GTx, Inc. (Nasdaq: GTXI) today announced that it has been added to the Russell 3000® Index as part of the Russell U.S. Indexes annual reconstitution. The addition will take effect after the...

GTx, Inc. to Participate in the Jefferies 2018 Global Healthcare Conference

GTx, Inc. (Nasdaq: GTXI) today announced that Robert J. Wills, PhD, Executive Chairman, will present a company overview at the Jefferies 2018 Global Healthcare Conference on Thursday, June...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

GTXI - Frequently Asked Questions (FAQ)

What is the current share price?
The current share price of is US$ 1.20
What is the 1 year trading range for share price?
has traded in the range of US$ 0.00 to US$ 0.00 during the past year

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
RNAZTransCode Therapeutics Inc
US$ 13.9515
(104.27%)
23.38M
SLXNSilexion Therapeutics Corporation
US$ 1.155
(99.14%)
182.83M
YIBOPlanet Image International Ltd
US$ 4.7203
(53.26%)
50.49M
TOIIWOncology Institute Inc
US$ 0.044
(46.67%)
17.06k
TRIBTrinity Biotech PLC
US$ 1.09
(43.42%)
101.42M
STSSSharps Technology Inc
US$ 0.43
(-70.55%)
12.96M
LPTXLeap Therapeutics Inc
US$ 0.6639
(-70.49%)
8.76M
SABSSAB Biotherapeutics Inc
US$ 2.23
(-48.85%)
963.17k
INKTMiNK Therapeutics Inc
US$ 5.05
(-42.87%)
120.38k
MGOLMGO Global Inc
US$ 0.1693
(-40.18%)
17.24M
NVDANVIDIA Corporation
US$ 126.3613
(6.71%)
313.99M
HEPAHepion Pharmaceuticals Inc
US$ 0.2291
(38.85%)
241.29M
SLXNSilexion Therapeutics Corporation
US$ 1.155
(99.14%)
182.83M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.5051
(22.57%)
164.25M
TRIBTrinity Biotech PLC
US$ 1.09
(43.42%)
101.42M

最近閲覧した銘柄

Delayed Upgrade Clock